WP1066, a small molecule inhibitor of the JAK/STAT3 pathway, inhibits ceramide glucosyltransferase activity.

Biochem Biophys Res Commun

Laboratory for Animal Cell Engineering, Niigata University of Pharmacy and Applied Life Sciences (NUPALS), 265-1 Higashijima, Akiha-ku, Niigata-shi, Niigata 956-8603, Japan. Electronic address:

Published: September 2017

WP1066 is a well-known inhibitor of the JAK/STAT3 signaling pathway. By a screen of known small molecule inhibitors of various enzymes and protein factors, we identified WP1066 as a ceramide glucosyltransferase inhibitor. Ceramide glucosyltransferase catalyzes the first glycosylation step during glycosphingolipid synthesis. We found that WP1066 inhibited the activity of ceramide glucosyltransferase with an IC of 7.2 μM, and that its action was independent of JAK/STAT3 pathway blockade. Moreover, the modes of inhibition of ceramide glucosyltransferase were uncompetitive with respect to both C-NBD-cermide and UDP-glucose.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2017.07.115DOI Listing

Publication Analysis

Top Keywords

ceramide glucosyltransferase
20
small molecule
8
inhibitor jak/stat3
8
jak/stat3 pathway
8
ceramide
5
glucosyltransferase
5
wp1066
4
wp1066 small
4
molecule inhibitor
4
pathway inhibits
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!